| Literature DB >> 19200624 |
Katrin Groebke Zbinden1, Lilli Anselm, David W Banner, Jörg Benz, Francesca Blasco, Guillaume Décoret, Jacques Himber, Bernd Kuhn, Narendra Panday, Fabienne Ricklin, Philippe Risch, Daniel Schlatter, Martin Stahl, Stefan Thomi, Robert Unger, Wolfgang Haap.
Abstract
Starting from a hit identified by focused screening, 3-aminopyrrolidine factor Xa inhibitors were designed. The binding mode as determined by X-ray structural analysis as well as the pharmacokinetic behaviour of selected compounds is discussed.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19200624 DOI: 10.1016/j.ejmech.2008.12.025
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514